Educational Notice
Peptidings provides information for educational and research purposes only. The peptides discussed on this page are subjects of ongoing scientific research. None of the information presented here constitutes medical advice or a recommendation for use. Consult a qualified healthcare provider before making any decisions about peptide use.
Browse by Condition
Wound Healing
Wound healing is one of the more biologically coherent areas of peptide research, and several compounds here have mechanistic cases that are genuinely well-developed in the preclinical literature. The challenge is the same as in most other categories: animal wound models translate poorly to human clinical outcomes, and the step from promising rodent data to a completed Phase II trial in humans has rarely been taken. GHK-Cu is the partial exception—decades of topical cosmetic use data exist, though route of administration remains a significant variable.
Approved Drug
Clinical Trials
Pilot / Human Data
Preclinical Only
It’s Complicated
Compounds with Research Relevant to Wound Healing
Each compound links to its full pillar article. The most useful sections for evaluating a specific application are the Claims vs. Evidence table and the Safety, Risks, and Limitations section. Evidence tiers reflect the strongest available data for a compound overall—not necessarily for this specific application.
WADA
BPC-157: What the Research Says about This Pentadecapeptide
Gastric pentadecapeptide studied for tissue repair, tendon healing, and gut protection. Pilot human data only; WADA prohibited.
Read the research →
GHK-Cu: What the Research Says about the Copper Peptide
Copper-binding tripeptide studied for wound healing, collagen synthesis, and skin remodeling. Evidence varies significantly by route of administration.
Read the research →
KPV (Lysine-Proline-Valine): Research Overview
C-terminal alpha-MSH tripeptide studied for anti-inflammatory effects in gut and wound models. Preclinical evidence only.
Read the research →
LL-37 (Cathelicidin): What the Research Shows
The only human cathelicidin, studied for antimicrobial activity and wound healing. Preclinical evidence only.
Read the research →
WADA
TB-500: What the Research Says about Thymosin Beta-4’s Synthetic Fragment
Synthetic Thymosin Beta-4 fragment studied for tissue repair and cell migration. Preclinical evidence only; WADA prohibited.
Read the research →
WADA
Thymosin Beta-4: What the Research Shows
Endogenous 43-amino acid actin-sequestering peptide studied for wound healing, cardiac repair (RGN-352 Phase II), and corneal regeneration (RGN-259). TB-500 is its synthetic fragment — distinct compounds.
Read the research →
Guides Relevant to This Condition
How to Reconstitute Lyophilized Peptides
Bacteriostatic water, reconstitution ratios, vial handling
Peptide Storage and Handling Best Practices
Temperature ranges, freeze-thaw cycles, reconstituted peptide shelf life
Peptide Injection Technique Guide
Subcutaneous and intramuscular injection, site rotation, safety
Research Cluster
These compounds are covered in depth in the Injury Recovery and Tissue Repair cluster hub.
Disclaimer: This page is for educational and research purposes only. It does not constitute medical advice, diagnosis, or treatment. The compounds discussed have not been evaluated by the FDA for all applications described. Consult a qualified healthcare provider before making any decisions about your health.
